Praxis Precision Medicines, Inc. (PRAX) short interest & options flow
NASDAQPraxis Precision Medicines is in an unusual position this week: a string of analyst upgrades and target increases arriving just as the stock pulls back nearly 10% from its post-earnings peak, widening an already dramatic gap between where the shares trade and where the Street thinks they belong. The analyst activity this week has been unusually active for a biotech in the days…
PRAX Wells Fargo upgrade to Overweight, target raised 48% to $509 from $343.
- Market cap
- $8.40B
- Next earnings
- 23 Feb 2027
Key data as of 22 Nov 2026

Latest signals on PRAX
- Analyst
PRAX Wells Fargo upgrade to Overweight, target raised 48% to $509 from $343.
PRAX news and analysis
RSSNo long-form analysis yet for PRAX. Pulse alerts and the live data picture are available on ORTEX.
Open PRAX on ORTEX →Want the live picture for PRAX?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for PRAX — free to start on ORTEX.
Sign up for free →Open PRAX on ORTEX